Precision or Gatekeeping? The Plain-Language Experiment Reshaping Scientific Publishing
The average research article in the United States is written for an audience of perhaps a few dozen specialists. Everyone else — policymakers, clinicians in adjacent fields, journalists, and the taxpaying public that funds much of the enterprise — encounters a wall of nominalized clauses, field-specific acronyms, and sentences that routinely stretch past forty words. Linguists have a name for this register: academic English, a dialect so standardized that automated tools can identify a scientific abstract with striking accuracy based on vocabulary alone. The question facing American publishing is no longer whether this register excludes people. It is whether the exclusion is a flaw or a feature.
The Economics of Obscurity
Technical language did not emerge from malice. Disciplinary shorthand allows researchers to compress complex ideas, and precision often demands terms that lack everyday equivalents. A "randomized, double-blind, placebo-controlled crossover design" communicates an entire methodology in six words to a trained reader.
But the same compression functions as a filter. A 2019 analysis of biomedical abstracts found readability scores that would require roughly seventeen years of education to parse — a level exceeding what most physicians, let alone the general public, possess. When the National Institutes of Health requires grantees to submit plain-language project summaries, it is acknowledging a structural problem: publicly funded science has become publicly illegible.
The consequences compound. Patients navigating clinical trial results, state legislators weighing environmental evidence, and school boards evaluating public health guidance all depend on intermediaries — journalists, advocacy organizations, or university press offices — to translate. Each translation introduces distortion, and each distortion erodes trust. Survey data from the Pew Research Center has repeatedly shown a widening partisan gap in confidence in scientists, and while the causes are multiple, a scientific literature that reads as deliberately impenetrable does little to counter perceptions of a distant, self-interested expert class.
The Summary Mandate Arrives
Several major publishers have begun experimenting with structural remedies. Some biomedical journals now require a "plain language summary" — a plain-English abstract written for a lay audience — alongside the technical version. Others have adopted structured summaries with readability targets, capping sentence length and mandating definition of all acronyms.
The results are instructive and uneven. Early assessments suggest plain-language summaries are read far more often than abstracts when both are freely available, and that they measurably improve comprehension among non-specialists. But quality varies enormously. Some summaries are genuine translations; others are technical abstracts with the jargon lightly sanded off, still written in the passive constructions and hedged qualifications that make scientific prose so difficult to absorb.
There is also a labor question. Scientists receive no professional credit for writing accessible summaries, no more than they do for peer review — a workforce problem this journal has documented elsewhere. Adding a second writing task to the publication pipeline, without recognition or training, risks producing boilerplate rather than communication.
Does Simplification Cost Accuracy?
The most serious objection is epistemic rather than practical. Scientific claims derive their meaning from qualification: effect sizes, confidence intervals, the careful distinction between association and causation. Critics argue that plain language flattens these distinctions, producing summaries that overstate certainty or strip away the caveats that make a finding honest.
The concern is legitimate, but the evidence suggests it is manageable. Linguists who study science communication generally find that the trade-off between accessibility and precision is less severe than assumed. The real losses tend to come not from simplification itself but from bad simplification — summaries written by authors who treat the task as an afterthought, or drafted to make findings sound more definitive than the data warrant.
This points toward a training problem rather than an inherent conflict. Writing for a lay audience is a craft, one that most doctoral programs in the United States do not teach. A handful of institutions have begun offering science communication coursework, and professional societies increasingly host workshops, but these efforts remain peripheral to the credentialing system that actually shapes scientific careers.
Toward a Bilingual Science
A more ambitious framing treats plain-language summaries not as a concession but as a second dialect — one that researchers should be as accountable for as the technical text itself. Under this model, the summary is peer-reviewed, indexed, and versioned alongside the article, with the same editorial standards applied to fidelity and accuracy.
There are precedents. Cochrane reviews have long paired technical evidence syntheses with plain-language summaries, and the practice has not visibly degraded the rigor of the underlying work. Federal agencies, bound by the Plain Writing Act of 2010, have demonstrated that government communication can be made comprehensible without becoming careless.
What would it take to generalize the model across American publishing? Journals would need to review summaries with real editorial attention. Promotion and tenure committees — the ultimate arbiters of scientific incentives — would need to count accessible writing as scholarly output. And the scientific community would need to retire the assumption that obscurity signals sophistication.
None of this resolves the deeper tension at the heart of the debate. Some ideas genuinely are difficult, and no amount of stylistic reform will make quantum field theory or causal inference intuitive to the untrained reader. But difficulty of ideas is not the same as difficulty of prose. The American scientific enterprise has conflated the two for a century, and the cost — in public trust, in interdisciplinary collaboration, in the civic standing of evidence itself — has been quietly accumulating ever since.
The experiment now underway in journals across the country deserves scrutiny, and its failures deserve honesty. But the burden of proof has shifted. A literature that cannot explain itself to the society that funds it is not merely inaccessible. It is, in a meaningful sense, unfinished.